Feb. 13, 2006 — Acacia Research Corp. (Nasdaq:CBMX) (Nasdaq:ACTG) announced Monday that its CombiMatrix group has begun work on a one year, $2.1 million contract with the U.S. Department of Defense (DoD). Funding for this contract was previously announced as part of the DoD budget.
CombiMatrix’s development program with the Department of Defense is focused on the integration of CombiMatrix’s biotechnology with microelectronics and microfluidics and the development of an automated system. CombiMatrix is seeking to develop systems for a broad range of requirements from portable hand-held devices to larger industrial units. CombiMatrix’s integrated detection system is targeting potential threats such as Anthrax, plague, toxins, and other agents that could be used as bioweapons by terrorists and other enemies.